NCT00141375View on ClinicalTrials.gov

To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

January 31, 2006

Conditions
Neuropathic Pain
Interventions
DRUG

Pregabalin

Trial Locations (7)

2036

Pfizer Investigational Site, Little Bay

2065

Pfizer Investigational Site, St Leonards

2502

Pfizer Investigational Site, Warrawong

3084

Pfizer Investigational Site, Heidelberg

4102

Pfizer Investigational Site, Woolloongabba

6008

Pfizer Investigational Site, Shenton Park

Unknown

Pfizer Investigational Site, NSW

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00141375 - To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury. | Biotech Hunter | Biotech Hunter